RE: Accustem17 Jan 2021 13:30
plenty of examples of Biotechs that have no revenue, make big losses and have mcaps of hundreds of millions, in some cases billions, it's all about the pipeline, the IP and the future projections of revenue, cash generation and buyout prospects